Kurzfassung

An Eighteen-Month, Two-Arm, Randomized, Double-
Masked, Multi-center, Phase III Study Assessing the
Efficacy and Safety of Brolucizumab versus Aflibercept in
Adult Patients with Visual Impairment due to Macular
Edema secondary to Branch Retinal Vein Occlusion